HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,617-2,628 of 4,505
Drug study icon
TerminatedNCT00998608

Risperidone Versus Risperidone Plus Low Dose of Haloperidol for schizophrenia

Official study title

A Randomized, Double-Blind, Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Combined With Low Dose of Haloperidol in the Treatment of Schizophrenic Disorder

This study ended early.

In Kaohsiung City
SchizophreniaMedication studyAges 18–55
Countries
Taiwan
Sponsor
Kaohsiung Kai-Suan Psychiatric Hospital
Behavioral study icon
CompletedNCT04040998

Compensatory Cognitive Training For Schizophrenia

Official study title

Compensatory Cognitive Training for Psychosocial Correlates and Self-stigma in Persons With Schizophrenia

This study has finished and is no longer accepting participants.

In Taoyuan
SchizophreniaBehavioural studyAges 20–65
Countries
Taiwan
Sponsor
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan
Behavioral study icon
CompletedNCT01055509

Compensatory Strategies Applied to Cognitive Impairment in Schizophrenia

Official study title

Effectiveness of Cognitive Adaptation Training Applied to Cognitive Impairment in Schizophrenia - A Randomised Trial

This study has finished and is no longer accepting participants.

Multiple locations, including Aabenraa
SchizophreniaBehavioural studyAges 18–70
Countries
Denmark
Sponsor
University of Southern Denmark
Behavioral study icon
TerminatedNCT00184509

Continued Early Intervention for Recent-onset Schizophrenia

Official study title

Continued Early Intervention for Recent-onset Schizophrenia. A Randomized Controlled Study.

This study ended early.

In Trondheim
SchizophreniaBehavioural studyAges 18–35
Countries
Norway
Sponsor
Norwegian University of Science and Technology
Drug study icon
CompletedNCT00140192

Creatine Treatment in Psychiatric Disorders

Official study title

Creatine as a New Treatment for Schizophrenia:A Double-Blind Trial

This study has finished and is no longer accepting participants.

In Beersheva
SchizophreniaMedication studyAges 18–60
Countries
Israel
Sponsor
Beersheva Mental Health Center
Other study type icon
CompletedNCT03317769

Creating Live Interactions to Mitigate Barriers

Official study title

Creating Live Interactions to Mitigate Barriers (CLIMB): A Mobile Intervention to Improve Social Functioning in People With Schizophrenia

This study has finished and is no longer accepting participants.

In San Francisco
SchizophreniaInterventional studyAges 18–60
Countries
United States
Sponsor
Posit Science Corporation
Drug study icon
CompletedNCT02298985

Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients

Official study title

Curcumin as add-on to Antipsychotic Treatment in Chronic Schizophrenia Patients: A Randomized, Double-Blind, Placebo-controlled Study

This study has finished and is no longer accepting participants.

Multiple locations, including Beersheva
SchizophreniaMedication studyAges 18–60
Countries
Israel
Sponsor
Beersheva Mental Health Center

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.